Easterly Investment Partners’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,350
Closed -$9.54K 191
2025
Q1
$9.54K Hold
3,350
﹤0.01% 185
2024
Q4
$19.7K Hold
3,350
﹤0.01% 196
2024
Q3
$14.9K Hold
3,350
﹤0.01% 201
2024
Q2
$88.8K Hold
3,350
0.01% 195
2024
Q1
$91.8K Hold
3,350
0.01% 202
2023
Q4
$81.4K Hold
3,350
0.01% 189
2023
Q3
$67.7K Hold
3,350
0.01% 183
2023
Q2
$98.8K Hold
3,350
0.01% 193
2023
Q1
$83.8K Hold
3,350
0.01% 188
2022
Q4
$106K Hold
3,350
0.01% 182
2022
Q3
$99K Hold
3,350
0.01% 185
2022
Q2
$102K Hold
3,350
0.01% 181
2022
Q1
$452K Buy
3,350
+600
+22% +$63.3K 0.03% 168
2021
Q4
$358K Buy
+2,750
New +$348K 0.03% 175

Other funds holding LONA

Easterly Investment Partners's LONA Position: Q2 2025 in Review

Easterly Investment Partners sold out of LeonaBio Inc (LONA) in Q2 2025, closing a stake of 3,350 shares — an estimated $9.54K sold.

Easterly Investment Partners first reported a position in LONA in Q4 2021 and held it in 14 quarters. The position peaked at $452K in Q1 2022. 50 funds tracked by Wall St. Rank hold LONA as of Q2 2025.

  • Easterly Investment Partners reported no remaining LeonaBio Inc position as of Q2 2025 after selling out during the quarter.
  • Easterly Investment Partners sold 3,350 LeonaBio Inc shares in Q2 2025, an estimated $9.54K.
  • Easterly Investment Partners first reported a position in LeonaBio Inc in Q4 2021 and held it in 14 quarters.
  • Easterly Investment Partners's LeonaBio Inc position peaked at $452K in Q1 2022.
  • 50 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2025.

Based on Easterly Investment Partners's 13F filing for Q2 2025, filed 29 Jul 2025.